We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Nepal’s Ministry of Health has reported 23,127 suspected dengue cases as of 4 September with 14 deaths confirmed across 75 districts. The province of Koshi in the East has reported 76% of the cases to-date, followed by neighbouring Bagmati Provicne with 14% of the cases. The top 5 districts affected are Sunsari, Morang, Dhading, Jhapa and Kathmandu. The majority of cases (66%) have occurred in August 2023.
Dengue is an infection found in tropical and sub-tropical climates worldwide. Dengue is spread by Aedes mosquito bites and can cause a severe flu-like illness.
All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection.
Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.
A new dengue vaccine Qdenga® has been licensed in the UK and is awaiting JCVI recommendations for use.
Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.
For further information see TRAVAX dengue fever page.
